Patented Drug Spending To Reach US$2.5bn By 2014

BMI calculates that the value of Egypt's patented drug market will rise from US$1.60bn in 2009 to US$2.5bn by 2014, representing a compound annual growth rate (CAGR) of 9.6%. By 2019 this figure will reach US$3.2bn, at a slower CAGR of 7.3% in the interim period. However, we also believe that patented drug spending will decrease as a proportion of the total pharmaceutical spend, from 65.1% in 2009 to 59.8% by 2014.

To read the full article, please choose one of the following options: